A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

Cited by (245)

Items 101–200 of 245

1. Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study
   Jingping Zhao, Lehua Li, Jianguo Shi, Yi Li, Xiufeng Xu, Keqing Li, Lili Zhang, Shangli Cai, Yu Feng, Jianmin Zhuo et al. · 2017 · Neuropsychiatric Disease and Treatment
2. Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran
   Omran Davarinejad, Tahereh Mohammadi Majd, Farzaneh Golmohammadi, Payam Mohammadi, Farnaz Radmehr, Mostafa Alikhani, Tayebeh Motaei, Mehdi Moradinazar, Annette Beatrix Brühl, Dena Sadeghi Bahmani et al. · 2021 · International Journal of Environmental Research and Public Health
3. Update of the World Health Organization’s Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia)
   Carolin Lorenz, Irene Bighelli, Fahmy Hanna, Aemal Akhtar, Stefan Leucht · 2024 · Schizophrenia Bulletin
4. Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients
   Lui, Simon S.Y., Lam, Jessica P.Y., Lam, Joanna W.S., Chui, William W.H., Mui, Jolene H.C., Siu, Bonnie W.M., Cheng, K.M., Cheung, Eric F.C., Chan, Raymond C.K. · 2021 · Asian Journal of Psychiatry
5. Assessing beliefs and attitudes towards antipsychotic medication from a recovery-based perspective: Psychometric properties of a new scale
   Maria João Martins, Ana Margarida Pinto, Paula Castilho, António Macedo, Ana Telma Pereira, M. Bajouco, R. Almeida Leite, Ondina Matos, Sofia Morais, Nuno Gonçalo Gomes Fernandes Madeira et al. · 2019 · Psychiatry Research
6. Understanding Helpful Nursing Care From the Perspective of Mental Health Inpatients With a Dual Diagnosis: A Qualitative Descriptive Study
   Lydia Ould Brahim, Cezara Hanganu, Catherine Pugnaire Gros · 2019 · Journal of the American Psychiatric Nurses Association
7. Exploring contextual factors impacting the implementation of and engagement with a digital platform supporting psychosis recovery: A brief report
   Lydia Sequeira, Iman Kassam, Jessica D’Arcey, Wenjia Zhou, Sana Junaid, Sherry Luo, Navi Boparai, Leah Tackaberry-Giddens, Sean A. Kidd · 2023 · Translational Behavioral Medicine
8. Psychometric Properties of Scale to Assess the Therapeutic Relationship—JapaneseVersion (STAR-J)
   Asami Matsunaga, Sosei Yamaguchi, Utako Sawada, Takuma Shiozawa, Chiyo Fujii · 2019 · Frontiers in Psychiatry
9. A Digital Intervention Using Daily Financial Incentives to Increase Medication Adherence in Severe Mental Illness: Single-Arm Longitudinal Pilot Study
   Daniel Guinart, Michael Sobolev, Bhagyashree Patil, Megan Walsh, John Michael Kane · 2022 · JMIR Mental Health
10. How Counseling Based on Acceptance and Commitment Therapy and Supported With Motivational Interviewing Affects the Perceptions of Treatment Motivation in Patients Diagnosed With Schizophrenia: A Qualitative Study
    Erman Yıldız, Rukuye Aylaz · 2020 · Journal of the American Psychiatric Nurses Association
11. The role of insight, social rank, mindfulness and self‐compassion in depression following first episode psychosis
    Jamie R. Hardman, John Gleeson, César González‐Blanch, Mario Álvarez‐Jiménez, Madeleine I. Fraser, Keong Yap · 2023 · Clinical Psychology & Psychotherapy
12. Evaluation of a flexible assertive community treatment (FACT) program for patients with severe mental illness: an observational study in Salzburg, Austria
    Matthias G. Tholen, Anna Martin, Theresa Stemeseder, Thomas Vikoler, Barbara Wageneder, Wolfgang Aichhorn, Andreas Kurt Kaiser · 2024 · International Journal of Mental Health Systems
13. Temporal associations between medication adherence for patients with schizophrenia and opioid dependence: A 17-year Canadian Cohort Study
    Stefanie N. Rezansoff, Akm Moniruzzaman, Julian M. Somers · 2019 · Schizophrenia Research
14. Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics
    Carlos De las Cuevas, José de León · 2020 · Patient Preference and Adherence
15. Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies
    Dan L. McElroy, Andrew J. Roebuck, Gavin A. Scott, Quentin Greba, Sumanta Garai, Eileen M. Denovan‐Wright, Ganesh A. Thakur, Robert B. Laprairie, John G. Howland · 2021 · Psychopharmacology
16. Advanced practice nurses led clinic in a psychiatric hospital: An outcome evaluation in Singapore
    Xu, Changqing, Xie, Huiting, Zhou, Zhenyu, Govindasamy, Arumugum, Mao, Rui, Chan, Yiong Huak · 2020 · Archives of Psychiatric Nursing
17. Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia
    Christopher Zacker, Justin T. Puckett, Sachin J. Kamal‐Bahl · 2024 · ClinicoEconomics and Outcomes Research
18. Treatment Duration With Long-Acting Injectable Antipsychotics After In-hospital Initiation
    Hans Rittmannsberger, Jan Rosenleitner, Gertraud Malsiner‐Walli, Regina Werl, Barbara Rittmannsberger, Kurosch Yazdi · 2017 · Journal of Clinical Psychopharmacology
19. Does Non-Adherence Increase Treatment Costs in Schizophrenia?
    Mark Pennington, Paul McCrone · 2018 · PharmacoEconomics
20. Effects of the T-type calcium channel antagonist Z944 on paired associates learning and locomotor activity in rats treated with the NMDA receptor antagonist MK-801
    Andrew J. Roebuck, Wendie N. Marks, Max C. Liu, Nimra B. Tahir, Nadine K. Zabder, Terrance P. Snutch, John G. Howland · 2018 · Psychopharmacology
21. Hospital and patient factors influencing the health status among patients with schizophrenia, thirty days after hospital discharge: multi-level analysis
    Anantree Smithnaraseth, Acharaporn Seeherunwong, Rungnapa Panitrat, Mathuros Tipayamongkholgul · 2020 · BMC Psychiatry
22. Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia
    Bárbara Iruretagoyena, Carmen Paz Castañeda, Cristián Mena, Camila Díaz, Rubén Nachar, Juan Pablo Ramírez-Mahaluf, Alfonso González‐Valderrama, Juan Pablo Undurraga, James Hunter MacCabe, Nicolas Andres Crossley · 2021 · Schizophrenia Research
23. Cost-effectiveness of aripiprazole orally disintegrating tablets in the treatment of schizophrenia in China
    Ziyi Lin, Jianwei Xuan · 2020 · Expert Review of Pharmacoeconomics & Outcomes Research
24. Exploring the relationship of insight with psychopathology and gender in individuals with schizophrenia spectrum disorders with structural equation modelling
    Jesús Cobo, Javier Labad, Esther Pousa, Lourdes López Nieto, Susana Ochoa, Judith Usall, Carles García-Ribera, Iris Baños, Beatríz González, Carmina Massons et al. · 2020 · Archives of Women s Mental Health
25. Mapping the literature on parents with mental illness, across psychiatric sub-disciplines: a bibliometric review
    Njål Andersen, Ingunn Olea Lund · 2020 · BMC Psychiatry
26. Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis
    Marian Surmann, Sebastian Falke, Lara von Gruchalla, Birgit Maisch, Christina Uhlmann, Volker Arolt, Rebekka Lencer · 2020 · Psychiatry Research
27. Medication Adherence and Influencing Factors Among Patients With Severe Mental Disorders in Low-Income Families During COVID-19 Outbreak
    Huiying Wang, Fengju Yao, Hailing Wang, Changhong Wang, Zhengjun Guo · 2022 · Frontiers in Psychiatry
28. Acceptability of point of care testing for antipsychotic medication levels in schizophrenia
    Matthew Atkins, David M. Taylor, Robert Harland, Aaron Brewer, Sophie Williams, Edward Chesney, Philip K. McGuire · 2022 · Psychiatry Research Communications
29. Exploring the “Insight Paradox” in TreatmentResistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine
    Süleyman Dönmezler, Gizem İskender, Nurhan Fıstikçı, Yavuz Altunkaynak, Sevinç Ulusoy, Tonguç Demir Berkol · 2023 · ALPHA PSYCHIATRY
30. Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
    Mulualem Admasu Kelebie, Getasew Kibralew, Gebresilassie Tadesse, Gidey Rtbey, Mekidem Aderaw, Wondale Endeshaw, Mitiku Belachew, Mulu Muche, Diemesew Getnet, Setegn Fentahun · 2025 · Scientific Reports
31. Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia
    Frank E. Zongo, Jocelyne Moisan, Jean‐Pierre Grégoire, ALAIN D. LESAGE, Richi Dossa, Sophie Lauzier · 2016 · Research in Social and Administrative Pharmacy
32. Would I take antipsychotics, if I had psychotic symptoms? Examining determinants of the decision to take antipsychotics
    Fabrice Sébastien Berna, Anja S. Göritz, Pierre‐Michel Llorca, Pierre Vidailhet, Guillaume B. Fond, Steffen Moritz · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
33. Comparison of clinician-rated and self-report insight in Korean patients with schizophrenia using VAGUS insight scale
    Seong Hoon Jeong, In‐Won Chung, Hee Yeon Jung, Samuel Suk-Hyun Hwang, Se Hyun Kim, Tak Youn, Jun Ku Chung, Yong Sik Kim · 2017 · Psychiatry Research
34. Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study
    Dulcinea Vega, Francisco J. Acosta, Pedro Saavedra · 2020 · World Journal of Psychiatry
35. Medication adherence and needs among patients with schizophrenia in China: a qualitative study
    Xuping Li, Shuiyuan Xiao, Yajun Sun, Ying Zheng, Jiaju Huang, Ning Wei, Chun Mao, Shengjun Zhang, Yongyong Teng · 2025 · BMJ Open
36. Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency ward
    Claudio Brasso, Marta Cisotto, Camilla Ghirardini, Filippo Pennazio, Vincenzo Villari, Paola Rocca · 2021 · Psychiatry Research
37. Satisfaction with antipsychotics as a medication: the role of therapeutic alliance and patient-perceived participation in decision making in patients with schizophrenia spectrum disorder
    R. Torrecilla-Olavarrieta, Jose I. Pérez‐Revuelta, Edgar García‐Spínola, Ángela López Martín, José María Mongil-SanJuan, Carmen Rodríguez‐Gómez, José María Villagrán Moreno, Francisco González‐Sáiz · 2020 · International Journal of Psychiatry in Clinical Practice
38. Insight's level in borderline personality disorder, questioning consciousness
    Sylvia S. Martin, Pierluigi Graziani, Jonathan Del-Monte · 2020 · Journal of Affective Disorders Reports
39. The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
    Gabriela Visini, Samara J. Brown, Katrina Weston–Green, Cynthia Shannon Weickert, Rose Chesworth, Tim Karl · 2022 · Frontiers in Cellular Neuroscience
40. Adherence to psychopharmacological treatment in patients with severe and persistent mental disorders: A systematic review
    María José Alvear Velásquez, Iván Patricio Sandoval Carrión · 2024 · Revista Colombiana de Psiquiatría (English ed )
41. Motivational Interviewing in Patients with Acute Psychosis: A Feasibility Study
    Janani Panchalingam, Rahel Horisberger, Claudio Corda, Nicolas Kleisner, Julia Krasnoff, Achim Burrer, Tobias R. Spiller, Victoria Edkins, Erich Seifritz, Philipp Homan · 2025 · Schizophrenia Bulletin Open
42. Insight Into Illness and Defense Styles in Schizophrenia
    Yasuhiro Ogawa, Keita Fukuhara, Hiroyuki Tanaka, Yuma Nagata, Daiki Ishimaru, Takashi Nishikawa · 2019 · The Journal of Nervous and Mental Disease
43. Neurocognitive and clinical correlates of insight in schizophrenia
    Dhanya Raveendranathan, Jessie Joseph, Tanya Machado, Ashok V. Mysore · 2020 · Indian Journal of Psychiatry
44. Start low, go fast? Antipsychotic titration patterns at an inpatient psychiatric hospital
    Nina Vadiei, Jonathan Chien, Jude Enwereji, Britt Myslinski, Alexander Guzman · 2020 · Mental Health Clinician
45. Psychiatric Medication Changes Associated With Increased Rate of Medical Readmissions in Patients With Serious Mental Illness
    Hayley Drew Germack, Guy Weissinger, Zhadyra Bizhanova, Grant R. Martsolf · 2020 · The Journal of Nervous and Mental Disease
46. Psychopathology and Poor Clinical Insight in Psychotic Patients
    Mojtaba Habibi, Seyed Ruhollah Hosseini, Pardis Salehi Yegaei, Shahram Moradi, Paul Henry Lysaker · 2022 · The Journal of Nervous and Mental Disease
47. Metacognition and insight dynamics exploration in borderline personality disorder: Exploring the underlying dynamics.
    S. Martin, J. Del-Monte · 2023 · Journal of Psychiatric Research
48. Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults
    Ludovic Samalin, Ludivine Boudieu, Pierre‐Michel Llorca · 2024 · Expert Review of Neurotherapeutics
49. Expanding Outcome Measures in Schizophrenia Research: Does the Research Domain Criteria Pose a Threat?
    Phoebe Friesen · 2019 · Philosophy, psychiatry & psychology
50. Family Support and Adherence to Treatment in Patients Diagnosed with Schizophrenia in Tabasco, Mexico: A Case- Series Study
    Homero Daniel Hernandez-Yánez, Jorge E. Reyes-Tovilla, Isela Esther Juárez‐Rojop · 2015 · Journal of psychiatry
51. Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data
    Erica L. Stockbridge, Nathaniel J. Webb, Eleena Dhakal, Manasa Garg, Abiah D. Loethen, Thaddeus L. Miller, Karabi Nandy · 2021 · BMC Health Services Research
52. Real-World Prescribing Patterns of Long-Acting Injectable Antipsychotics in Australian Psychiatric Inpatients: Trends, Clinical Outcomes, and Substance Use Prevalence
    Tumilara Akindele, Kanchana De Alwis · 2025 · Drugs - Real World Outcomes
53. Non-adherence with the treatment regimen and its associated factors among patients with schizophrenia in Sub-Saharan Africa: a systematic review and meta-analysis
    Zenaw Debasu Addisu, Desalegn Getnet Demsie, Chernet Tafere, Ebrahim Abdela Siraj, Taklo Simeneh Yazie, Eyob Getaneh Yimer, Nigus Getaneh Alemu, Yonas Zewdu Milikit, Bamlak Nigussu Wabela, Malede Berihun Yismaw et al. · 2025 · Scientific Reports
54. Why using “consciousness” in psychotherapy? Insight, metacognition and self-consciousness
    Sylvia S. Martin · 2023 · New Ideas in Psychology
55. Association of somatic comorbidity and treatment adherence in patients with psychotic disorder
    J. Leijala, Olli Kampman, Jaana Suvisaari, Saana Eskelinen · 2024 · Journal of Psychiatric Research
56. Pharmacist-led Si-care (schizophrenia care) model to improve medication adherence and symptom management in schizophrenia
    Noor Cahaya, Susi Ari Kristina, Anna Wahyuni Widayanti, James Green · 2024 · Exploratory Research in Clinical and Social Pharmacy
57. Psychopharmakotherapie bei älteren Menschen mit schweren psychischen Erkrankungen
    Christian Lange‐Asschenfeldt · 2018 · Zeitschrift für Gerontologie und Geriatrie
58. Factors Influencing Adherence to Antipsychotic Medications in Women with Delusional Disorder: A Narrative Review
    Alexandre González-Rodríguez, José Antonio Monreal, Mary V. Seeman · 2022 · Current Pharmaceutical Design
59. Pharmacy switch of antipsychotic medications: patient’s perspective
    Sławomir Murawiec, Aleksandra Rajewska‐Rager, Jerzy Samochowiec, Sylwia Kalinowska, Jacek Kurpisz, J Krzyzanowska, Halina Sienkiewicz‐Jarosz, Iwona Kurkowska‐Jastrzębska, Agnieszka Samochowiec, Przemysław Bieńkowski · 2015 · Annals of General Psychiatry
60. Examining the role of insight, social support, and barriers in treatment engagement in individuals diagnosed with psychotic disorders
    Madeline Ward, Sarah Hope Lincoln · 2025 · Psychiatry Research
61. Pharmacogenomics-guided treatment versus conventional treatment in patients with Schizophrenia: Evaluation of medication adherence and switching rate
    Jiaqi Wang, Yuhang Yan, Liguang Duan, Binliang Tong, Xiaochuan Zhao, Shi Su, Mengqiang Zhao, Chaoli Chen, Yang Lun, Yueyao Luan et al. · 2025 · European Journal of Clinical Pharmacology
62. Factors contributing to family resilience in the context of schizophrenia: a descriptive qualitative study
    Yubin Chen, Linghui Zhang, Jiayuan Zhang, Hong Yu, Yuqiu Zhou, Qi Li, Xiaoyan Li · 2025 · BMC Psychiatry
63. Investigating the Effect of Adherence to Antipsychotic Therapy on the Length of Stay and Number of Hospitalizations in Patients with Schizophrenia – A Descriptive Analysis
    Melisa Intan Barliana, Dwi Aulia Ramdini, Nadiya Nurul Afifah, Sofa Dewi Alfian, Sri Adi Sumiwi · 2023 · Patient Preference and Adherence
64. Adverse events and treatment failure leading to discontinuation of recently approved antipsychotic drugs in schizophrenia: A network meta-analysis
    Fernanda S. Tonin, Thais Piazza, Astrid Wiens, Fernando Fernández-Llimós, Roberto Pontarolo · 2015 · Schizophrenia Research
65. Patient perceptions of schizophrenia in forensic and general adult psychiatry
    Emma L. E. Wall, David Mirfin, Sarah Jane White, Gillian Mezey · 2017 · Journal of Forensic Psychiatry and Psychology
66. Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia
    Unax Lertxundi, Rafael Hernandez, Beatriz Corcóstegui, Olatz Ibarra Barrueta, Gorka Mentxaka, Juan Medrano · 2018 · Medicine
67. Evaluation of Prescribing Patterns of Long-Acting Injectable Antipsychotics Within a Community Health System
    Jared Netley, Jamie Gaul, Chelsea L. Ferguson · 2019 · Journal of Clinical Psychopharmacology
68. Assessing Caregivers’ Adherence to Child Primary Care Recommendations: Development and Validation of a Scale
    Susana Sofia Monteiro Mourão, Sónia Figueira Bernardes, Helena Carvalho · 2020 · Child Care in Practice
69. Effective strategies for nurses empowering the life quality and antipsychotic adherence of patients with schizophrenia
    Saida El-Azzab, Entisar Mohammed Mahmoud Abu Salem · 2018 · Journal of Nursing Education and Practice
70. Working with People with Mental Health Difficulties to Improve Adherence to Medication
    Thomas R. E. Barnes, Peter Michael Haddad · 2020
71. Psychometric evaluation of the Arabic language version of the Birchwood Insight Scale in patients with schizophrenia
    Feten Fekih‐Romdhane, Zeinab Bitar, Fadila Al Mouzakzak, Ghinwa Abilmona, Oussama Dahdouh, Souheil R. Hallit · 2024 · BMC Psychiatry
72. Treatment adherence in first-episode psychosis: A one-year follow-up study comparing self-reported adherence, pharmacy refill data, and therapeutic drug monitoring
    J. Leijala, Olli Kampman, Teemu Gunnar, Jaana Suvisaari · 2025 · Psychiatry Research
73. Attitude toward antipsychotics and its correlation with psychopathology and insight in patients with schizophrenia
    RakeshKumar Chadda, Mamta Sood, AshwaniKumar Mishra, Kalpana Kumari, Ritushree Kukreti · 2018 · Indian Journal of Social Psychiatry
74. Deprescribing in mental health: pragmatic steps for a better quality of life
    Nana Tomova, A.D. Hale, Michelle Kruschandl · 2021 · Journal of Prescribing Practice
75. Knowledge of the treatment in schizophrenia and schizoaffective disorder and its relationship with nonadherence.
    Francisco J. Acosta, Dulcinea Vega, Pedro Saavedra · 2023 · Actas Españolas de Psiquiatría
76. Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia
    Kristin Richards, Michael T. Johnsrud, Christopher Zacker, Rahul Sasané · 2024 · Patient Preference and Adherence
77. Hubungan Dukungan Keluarga dengan Kepatuhan Pengobatan Pasien Rawat Jalan Skizofrenia di RSUD Banyumas
    Alfu Wa Ichda, Laksmi Maharani, Masita Wulandari Suryoputri · 2019 · Journal Syifa Sciences and Clinical Research
78. Factors associated with drug attitude in patients with schizophrenia spectrum disorders
    Lillian Harber, Hiroyoshi Takeuchi, Carol Borlido, Reza Hamidian, Gary J. Remington · 2017 · Schizophrenia Research
79. The Challenge of Nonadherence in Schizophrenia
    Ryan E. Lawrence, Lisa B. Dixon · 2019 · Springer eBooks
80. From Pills to Practices: Interpretative Phenomenological Analysis of Medication Experience and Self-Management in Schizophrenia
    Linghui Zhang, Yubin Chen, Hong Yu, Jiayuan Zhang, Yujing Sun, Qi Li, Yuqiu Zhou · 2024 · Qualitative Health Research
81. Understanding the metacognition and impulsivity issues with clinical and cognitive insight in borderline personality disorder – A cross sectional study
    Rajnish Raj, Aaliya Khanam, Zaid Ahmad Wani, Afifa Afreen, Simranjeet Kour, Ajaz A. Khan, Inaamul Haq · 2025 · Industrial Psychiatry Journal
82. Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study
    Monika Schlögelhofer, Ashleigh Peng Lin, Connie Markulev, Miriam R. Schäfer, Patrick D. McGorry, Barnaby Nelson, Rebekah Street, Nilufar Mossaheb, Stefan Smesny, Ian Bernard Hickie et al. · 2025 · Australian & New Zealand Journal of Psychiatry
83. BİR TOPLUM RUH SAĞLIĞI MERKEZİNDEKİ HASTALARDA TIBBİ TEDAVİYE UYUMUN İNCELENMESİ
    Nevin Onan · 2020 · Sağlık Bilimlerinde Değer
84. Effectiveness of financial incentives for long-acting injectable antipsychotic adherence in patients with psychotic and bipolar disorders: a systematic review protocol
    Raghib Dennis, Robin Christian, Michelle J. Palokas · 2019 · The JBI Database of Systematic Reviews and Implementation Reports
85. What determines immigrant caregivers’ adherence to health recommendations from child primary care services? A grounded theory approach
    Susana Mourão, Sónia Figueira Bernardes · 2019 · Primary Health Care Research & Development
86. Relation of medication adherence to cognitive functions in egyptian patients with bipolar I disorder
    Afaf Hamed Khalil, Heba Hamed ElShahawi, Ahmed Saber Abdelgawad, Mai SeifElDin Abdeen, Doha Mustafa El Serafi, Sherien Ahmed Khalil · 2021 · International Clinical Psychopharmacology
87. What Do Patients Want? Patient Satisfaction and Treatment Engagement
    Ann E. Webb, Robin E. Gearing · 2020
88. Understanding medication nonadherence in a sample of Egyptian patients with schizophrenia in relation to illness severity and insight
    Marwa Abd El Meguid, Heba Eissawy, Walaa Sabry, Mostafa Bastawy, Doaa Ahmed Khalifa, Ramy Ali · 2016 · Middle East Current Psychiatry
89. Deprescribing in Psychiatry
    Swapnil Gupta, Rebecca A. Miller, John Daniel Cahill · 2019
90. The attitude of healthcare providers towards medication self‐management in hospitalized patients diagnosed with schizophrenia or bipolar disorders
    Elke Loots, Tinne Dilles, Sarah Hadouchi, Bart Van Rompaey, Manuel Morrens · 2023 · Journal of Psychiatric and Mental Health Nursing
91. Acceptance and commitment therapy applied to early psychosis: Therapeutic foundations and a narrative systematic review
    Josep Pena-Garijo, Tábata Baeza Mor, José Martı́nez-Raga · 2025 · World Journal of Psychiatry
92. Micronutrient therapy for pyrroluria: a retrospective analysis of patient acceptance
    Lena Zingg, Elena Pavicic, Norman Bitterlich, Petra Stute · 2026 · Archives of Gynecology and Obstetrics
93. Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychotic disorder- A nationwide register-linkage study
    Jeyaniroshan Jeyapalan, Heidi T. Taipale, A. Tanskanen, Jari Tiihonen, Ellenor Mittendorfer‐Rutz, Solja Niemelä · 2026 · Schizophrenia Research
94. Advancing Personalized Medicine in Psychiatry: A Descriptive Pilot Study Integrating Pharmacogenetics and Pharmacokinetics in Long-Acting Antipsychotic Treatment
    Almudena Gil-Rodríguez, Sheila Recarey-Rama, María Vidal Millares, Francisco José Toja-Camba, María Tajes, Verónica Prado-Robles, María José Durán-Maseda, Manuela Pérez García, Ana Rodríguez-Viyuela, Patricia Sánchez-Fariña et al. · 2026 · Pharmaceutics
95. Attitude Toward Illness and Treatment in Adherent Schizophrenia Patients: A Qualitative Study
    Shi Hyun Kang, Hey Won Lee · 2020 · 신경정신의학
96. Pharmacist medication instructions are associated with continued medication self-management in older adults: a retrospective observational study
    Eiji Kose, Hidetatsu Endo, Hiroko Hori, Shingo Hosono, Chiaki Kawamura, Yuta Kodama, Takashi Yamazaki, Nobuhiro Yasuno · 2021 · Journal of Pharmaceutical Health Care and Sciences
97. Adherencia al Tratamiento Psicofarmacológico de los Pacientes con Trastornos Mentales Graves y Persistentes: Revisión Sistemática
    María José Alvear Velásquez, Iván Patricio Sandoval Carrión · 2022 · Revista Colombiana de Psiquiatría
98. KRONİK RUHSAL BOZUKLUĞU OLAN HASTALARIN TIP DIŞI YARDIM ARAMA DAVRANIŞLARI VE İLAÇ UYUM DÜZEYLERİNİN BELİRLENMESİ
    Esma Ceren ŞİŞGİNOĞLU, Nesibe GÜNAY MOLU · 2024 · SDÜ Tıp Fakültesi Dergisi
99. Incremental healthcare costs among patients experiencing adverse events on oral antipsychotics: a real-world analysis of U.S. Medicare beneficiaries with schizophrenia
    Christopher Zacker, Justin T. Puckett, Sachin J. Kamal‐Bahl · 2025 · Current Medical Research and Opinion
100. Therapeutic relationship and concordance of client- and clinician-rated motivational goals in treatment of people with psychosis: an exploratory study
     Marialuisa Cavelti, Raphaela M. Tschuemperlin, Daniela Hubl, Zeno Kupper, Franz Caspar, Stefan Westermann · 2018 · Psychosis